This report is a result of an on-site licensure renewal inspection conducted on April 13-15, 17, and 20-22, 2026, by staff from the Department of Drug and Alcohol Programs, Bureau of Program Licensure. Based on the findings of the on-site inspection, Cen-Clear, Inc. was found not to be in compliance with the applicable chapters of 28 PA Code which pertain to the facility. The following deficiencies were identified during this inspection:
|
Plan of Correction
|
Observations
Based on a review of client records, the facility failed to document treatment plan updates every 60 days in four of seven records.
Client #1 was admitted on August 7, 2025, and discharged on March 9, 2026. A treatment plan update was completed on October 16, 2025, and the next
update was due no later than December 16, 2025; however, it was completed on December 17, 2025.
Client #2 was admitted on August 12, 2025, and discharged on March 16, 2026. A treatment plan update was completed on October 21, 2025, and the next
update was due no later than December 21, 2025; however, it was completed on January 13, 2026.
Client #3 was admitted on August 25, 2025, and discharged on March 31, 2026. A treatment plan update was completed on October 16, 2025, and the next
update was due no later than December 16, 2025; however, it was completed on January 2, 2026.
Client #7 was admitted on September 29, 2025, and was still active at the time of the inspection. A treatment plan update was completed on November 20, 2025, and the next update was due no later than January 20, 2026; however, it was completed on January 22, 2026.
These findings were reviewed with the facility staff during the licensing process.
|
Plan of Correction
Therapists and Clinical staff were re-educated on DDAP documentation requirements, policies and treatment plan timelines on 5/14/26.
To prevent recurrence, the agency has reviewed the implemented a treatment plan tracking tool to monitor due dates and completion status for all clients. Clinical supervisors will review paperwork compliance and clinician caseloads during all scheduled supervision sessions to ensure documentation is completed timely.
Monthly Quality Assurance reviews will be conducted to audit charts for compliance with treatment plan requirements, signatures, and documentation timelines. Any identified deficiencies will be addressed through corrective supervision, additional training, and ongoing monitoring.
The Program Director and Clinical Supervisors will be responsible for ensuring continued compliance with DDAP regulations and will review in supervisions monthly.
|